These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4050223)

  • 41. [Clinical picture and treatment of multiple sclerosis].
    Karlov VA; Makarov VA; Seleznev AN; Savina EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(2):185-9. PubMed ID: 6134408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment.
    Whitaker JN; Layton BA; Herman PK; Kachelhofer RD; Burgard S; Bartolucci AA
    Ann Neurol; 1993 Jan; 33(1):10-7. PubMed ID: 7684211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Trials with buclizine in association with essential aminoacids and vitamins of the B complex (Buclivit) in the treatment of loos of apetite in children].
    Camillo-Coura L; Soli Ade S; Bezerra LM
    Hospital (Rio J); 1968 Sep; 74(3):939-46. PubMed ID: 4387267
    [No Abstract]   [Full Text] [Related]  

  • 44. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination therapy in multiple sclerosis.
    Fernández O
    J Neurol Sci; 2007 Aug; 259(1-2):95-103. PubMed ID: 17507031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of repeated treatments with cladribine (2-chlorodeoxyadenosine) on blood counts in multiple sclerosis patients.
    Grieb P; Stelmasiak Z; Solski J; Nowicki J; Jakubowska B; Ryba M
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):323-7. PubMed ID: 8744654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?
    Bar-Or A; Oger J; Gibbs E; Niino M; Aziz T; Renoux C; Alatab S; Shi FD; Campagnolo D; Jalili F; Rhodes S; Yamashita T; Fan B; Freedman MS; Panitch H; Arnold DL; Vollmer T
    Mult Scler; 2009 Aug; 15(8):959-64. PubMed ID: 19667022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experience in using T-activin in multiple sclerosis patients].
    Gusev EI; Arion VIa; Aristova RA; Ivanokov AN; Tunkel' OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):168-74. PubMed ID: 6608843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pentoxifylline: is it useful in multiple sclerosis?].
    Prieto JM; Dapena D; Lema M; Ares B; Cacabelos P; Noya M
    Rev Neurol; 2001 Mar 16-31; 32(6):529-31. PubMed ID: 11353990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma galactocerebrosides in multiple sclerosis.
    Baumann N; Lemonnier M; Jacque C; Marteau R; Harpin ML; Lhermitte F
    Biomedicine; 1975 Nov; 23(9):387-90. PubMed ID: 1231938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antianemic effect of ampevit and orkomin].
    Zapadniuk VI; Bezverkhaia IS; Oranskaia SA
    Farmakol Toksikol; 1979; 42(4):392-5. PubMed ID: 477961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Multiple sclerosis patients' use of possibly ameliorative treatment].
    Dørup I; Mai J
    Ugeskr Laeger; 1986 Sep; 148(40):2572-4. PubMed ID: 3775959
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of metabolic alkalosis in a patient with dynamic torsion of the stomach].
    Bondarenko AV; Novikov GA; Ukolov VV; Nikiforov IuV
    Anesteziol Reanimatol; 1988; (3):60-2. PubMed ID: 3213994
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of patients with multiple sclerosis with transfer factor (author's transl)].
    Romano EL; Pulido M; Layrisse Z; Malavé I
    Acta Cient Venez; 1978; 29(1):49-52. PubMed ID: 757718
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment with a brain tissue hydrolysate. Clinical observations and results of experimental studies].
    Harrer G; Sommer H
    Neurol Neurochir Pol; 1974; 8(5):737-43. PubMed ID: 4215047
    [No Abstract]   [Full Text] [Related]  

  • 57. [Transdermal melanotropin therapy in multiple sclerosis?].
    Kiessling WR; Seuffer R; Dietz K
    Dtsch Med Wochenschr; 1987 Apr; 112(15):613. PubMed ID: 3829950
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter: Multiple sclerosis and diet.
    Matheson NA
    Lancet; 1974 Oct; 2(7884):831. PubMed ID: 4138349
    [No Abstract]   [Full Text] [Related]  

  • 59. [The clinical importance of determining nitrates in the blood in patients with disseminated sclerosis].
    Karlov VA; Khokhlov AP; Riazantsev VV; Navasardiants DG; Savin AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(5):27-30. PubMed ID: 8585371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Early results of a new stimulative therapy of premature].
    LUTATI UV; GRAMAGLIA L
    Minerva Ginecol; 1952 Nov; 4(15):596-8. PubMed ID: 13036709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.